MIRA INFORM REPORT

 

 

Report Date :

30.11.2013

 

IDENTIFICATION DETAILS

 

Name :

AKHIL HEALTHCARE PRIVATE LIMITED

 

 

Registered Office :

205 BBC Tower Opp Work Trade Centre, Sayajigunj, Baroda – 390 005, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

24.07.2003

 

 

Com. Reg. No.:

04-042667

 

 

Capital Investment / Paid-up Capital :

Rs.0.500 Million

 

 

CIN No.:

[Company Identification No.]

U24231GJ2003PTC042667

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BRDA02515C

 

 

PAN No.:

[Permanent Account No.]

AAECA3633Q

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Dealing in Pharmaceuticals, Chemicals, Beauty Care Raw Materials and Bulk Drugs.

 

 

No. of Employees :

25 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 72000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record.

 

However, trade relations are fair. Business is active. Payment terms are reported as usually correct.

 

The company can be considered for business dealings at usual trade terms and condition.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

INDIAN ECONOMIC OVERVIEW

 

The current downturn provides an opportunity to push ahead with reforms to accelerate growth, says the latest India Development Update report released by the World Bank. The report says that the adverse effects of rupee depreciation are likely to be offset by the gains in the exports performance due to improved external competitiveness. Since May this year, the local currency has depreciated substantially and fell to a record level of Rs 68.85 to a dollar on August, 28.

 

A stagflation like situation appears to have arisen as inflation jumped to an eight month high of 6.46 % for the month of September. It is up from 6.10 % in August. Growth continues to be muted with factory output plunging to 0.6 % in August. Onion prices have risen nearly 300 % from last September. Vegetables cost nearly 90 % more than they did last year. Wake up to the economic contribution of slum dwellers. They contribute more than 7.5 % to the country’s gross domestic product, according to a recent study conducted in 50 top cities.

 

136000 estimated number of jobs created during the second quarter of the current financial year. 50000 estimated number of additional jobs in the field of corporate social responsibility in the coming years.

 

The International Finance Corporation expects to come out with its rupee linked bonds issue before the end of 2013 as a part of its plan to raise $ 1 billion. The Apple iPhone 5c (Rs 41900 for 16 GB variant) and 5s (Rs 53500 for 16GB variant) has been launched in India from 1st November.

 

The Land Acquisition Act to provide just and fair compensation to farmers will come into force from January 1 next year, said Rural Development Minister Jairam Ramesh. The Act replaces a 119 year old registration. The Securities and Exchange Board of India has approved the trading of currency futures on the Bombay Stock Exchange. The exchange plans to launch the currency futures platform with advanced trading technology by the end of November.

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

LOCATIONS

 

Registered Office :

205 BBC Tower Opp Work Trade Centre, Sayajigunj, Baroda – 390 005, Gujarat, India

Tel. No.:

91-265-3018080/ 3013456/ 2362982/ 2363350

Fax No.:

91-265-3018667/ 2362982

E-Mail :

info@akhilhealthcare.com

akhilhealthcare@yahoo.com

Website :

www.akhilhealthcare.com

Location :

Owned

 

 

Branch Office :

78, Morden Complex, Sai Road, Baddi, Himachal Pradesh, India

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mr. Manoj Kumar Kanaiyalal Shah

Designation :

Director

Address :

13-14, Nanddham Duplex, Near, Vrajdham Temple, manjalpur, Vadodara – 390011, Gujarat, India

Date of Birth/Age :

01.06.1966

Date of Appointment :

24.07.2003

DIN No.:

00424419

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231GJ2003PTC042667

AKHIL HEALTHCARE PRIVATE LIMITED

Director

24/07/2003

24/07/2003

Active

NO

2

U24231GJ2004PTC044582

ZERON PHARMA PRIVATE LIMITED

Managing director

14/04/2012

10/08/2004

Active

NO

3

U24233GJ2006PTC049498

MEDILINK FINECHEM PRIVATE LIMITED

Director

30/11/2006

30/11/2006

Active

NO

4

U24232HP2007PTC030752

BLUE MARK HEALTH CARE PRIVATE LIMITED

Director

06/06/2007

06/06/2007

Active

NO

 

 

Name :

Ms. Nila Manoj Kumar Shah

Designation :

Director

Address :

13-14, Nanddham Duplex, Near, Vrajdham Temple, manjalpur, Vadodara – 390011, Gujarat, India

Date of Birth/Age :

26.07.1967

Date of Appointment :

24.07.2003

DIN No.:

00424470

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231GJ2003PTC042667

AKHIL HEALTHCARE PRIVATE LIMITED

Director

24/07/2003

24/07/2003

Active

NO

2

U24233GJ2006PTC049498

MEDILINK FINECHEM PRIVATE LIMITED

Director

30/11/2006

30/11/2006

Active

NO

3

U24233GJ2010PTC059787

SANTE SOIS MEDICAMENTS PRIVATE LIMITED

Director

06/03/2010

06/03/2010

Active

NO

 

 

MAJOR SHAREHOLDERS

 

AS ON 30.09.2013

 

Names of Shareholders

 

 

No. of Shares

Manoj Kumar Kanaiyalal Shah

 

30000

Nila Manoj Kumar Shah

 

20000

 

 

 

Total

 

50000

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 30.09.2013

 

Category

Percentage

Directors or relatives of Directors

100.00

 

 

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Dealing in Pharmaceuticals, Chemicals, Beauty Care Raw Materials and Bulk Drugs.

 

 

GENERAL INFORMATION

 

Customers :

·         Alembic Limited, Vadodara

·         Ato Z Pharmaceuticals Limited, Chennai

·         Bharat Parenterals Limited, Vadodara

·         Comed Chemicals Limited, Vadodara

·         Claris Lifescience Limited, Ahmedabad

·         Gujarat Liquis Caps Private Limited, Vadodara

·         Hellios Pharmaceuticals, Ahmedabad

·         Laborate Pharmaceuticals, Panipet

·         Intas Pharmaceuticals Limited, Ahmedabad

·         Lincoln Pharmaceuticals, Limited, Ahmedabad

 

 

No. of Employees :

25 (Approximately)

 

 

Bankers :

·         The Karur Vysya Bank Limited, 13, SIDCUP Tower, Race Course, Vadodra – 390005, Gujarat, India

·         HDFC Bank Limited

·         ICICI Bank Limited

 

 

Facilities :

Particulars

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

1.111

2.807

Short Term Borrowings

36.404

39.419

 

 

 

Total

37.515

42.226

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Y.K. Shah and Company

Chartered Accountants

Address :

217, Phoenix Complex, Near Suraj Plaza, Sayajigunj, Vadodara, Gujarat, India

Tel. No.:

91-265-2363315/ 3010788

E-Mail :

ykshahca@yahoo.com

PAN No.:

AFOPS7049Q

 

 

Enterprise under common control (EUC) :

·         Zeron Pharma Private Limited

·         Akhil Healthcare

·         Sante Sois Medicaments Private Limited

·         Medilink Finechem Private Limited

·         Lexine Technochem Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000

Equity Shares

Rs.10/- each

Rs.0.500 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000

Equity Shares

Rs.10/- each

Rs.0.500 Million

 

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.500

0.500

0.500

(b) Reserves & Surplus

17.735

13.140

9.892

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

18.235

13.640

10.392

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

1.111

2.807

2.167

(b) Deferred tax liabilities (Net)

0.497

0.458

0.054

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

1.608

3.265

2.221

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

36.404

39.420

20.920

(b) Trade payables

67.163

65.432

56.231

(c) Other current liabilities

4.506

4.343

2.343

(d) Short-term provisions

0.000

0.000

0.000

Total Current Liabilities (4)

108.073

109.195

79.494

 

 

 

 

TOTAL

127.916

126.100

92.107

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

3.528

3.204

3.000

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

3.528

3.204

3.000

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

17.848

21.877

22.736

(c) Trade receivables

98.690

96.919

63.564

(d) Cash and cash equivalents

5.936

2.752

1.769

(e) Short-term loans and advances

1.914

1.348

1.038

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

124.388

122.896

89.107

 

 

 

 

TOTAL

127.916

126.100

92.107

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

290.732

238.383

211.375

 

 

Increase / (Decrease) of Goods

 

0.000

5.344

 

 

Other Income

 

0.670

0.401

 

 

TOTAL                                     (A)

NA

239.053

217.120

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Purchase of Stock in Trade

 

212.330

194.420

 

 

Direct Expenses

 

3.983

2.584

 

 

Employee Benefit Expenses

 

3.330

3.667

 

 

Other Expenses

 

8.918

8.794

 

 

Increase / (Decrease) of Goods

 

0.859

0.000

 

 

TOTAL                                     (B)

NA

229.420

209.465

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

 

9.633

7.655

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

 

4.038

3.026

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

 

5.595

4.629

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

 

0.354

0.339

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

NA

5.241

4.290

 

 

 

 

 

Less

TAX                                                                  (H)

 

1.993

1.250

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

3.248

3.248

3.040

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

 

9.892

6.852

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

NA

13.140

9.892

 

 

 

 

 

 

Earnings Per Share (Rs.)

64.96

64.97

60.79

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

NA
1.36

1.40

 

 

 
 

 

Net Profit Margin

(PBT/Sales)

(%)

NA
2.20

2.03

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA
4.16

3.40

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA
0.38

0.29

 

 

 
 

 

Debt Equity Ratio

(Total Debt /Networth)

 

2.06
3.09

2.22

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

1.15
1.13

1.12

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

Yes

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

OPERATION:

During the year subject has achieved the sales of Rs.290.732 Millions (P.Y. Rs.238.383 Millions) and profit for the current year is Rs.3.248 Millions (P.Y. Rs.3.248 Millions) after tax.

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10283454

25/03/2011

27,500,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA – 390 015, GUJARAT, INDIA

B11246444

 

 

FIXED ASSETS:

 

·         Air Condition

·         Office Equipment

·         Delivery Van

·         Motor Car

·         Vehicles

·         Computer

·         Furniture and Fixtures

·         Electrical Installation


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.39

UK Pound

1

Rs.102.06

Euro

1

Rs.84.98

 

 

INFORMATION DETAILS

 

Report Prepared by :

NKT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

4

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.